Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
Giloteaux, Ludovic, Goodrich, Julia K, Walters, William A et al. · Microbiome · 2016 · DOI
Quick Summary
This study found that people with ME/CFS have different gut bacteria compared to healthy people. The bacteria in ME/CFS patients showed less diversity and included more potentially harmful species while having fewer beneficial ones. Additionally, researchers detected signs in the blood suggesting that bacteria or bacterial components may be leaking through the gut lining, which could contribute to inflammation and symptoms.
Why It Matters
This research provides biological evidence that gut microbiota changes are associated with ME/CFS, potentially explaining gastrointestinal symptoms reported by many patients. It opens new avenues for understanding disease mechanisms and suggests the gut microbiome could be a therapeutic target for intervention studies.
Observed Findings
Reduced bacterial diversity in ME/CFS patients compared to healthy controls, particularly affecting the Firmicutes phylum
Elevated blood levels of microbial translocation markers (LPS, LBP, sCD14) in ME/CFS patients
Altered bacterial composition with increased pro-inflammatory species and decreased anti-inflammatory species in patient samples
Significant correlations between LBP-LPS, LBP-sCD14, and LPS-sCD14 serum levels
82.93% classification accuracy for ME/CFS diagnosis using combined microbiome and inflammatory marker data
Inferred Conclusions
Dysbiosis of the gut microbiota is associated with ME/CFS
Microbial translocation may be occurring in ME/CFS patients, indicated by elevated bacterial products in the blood
Altered microbiota composition and increased intestinal permeability may contribute to the inflammatory symptoms observed in ME/CFS
Microbiome and inflammatory markers together could serve as potential biomarkers for ME/CFS diagnosis
Remaining Questions
Does dysbiosis cause ME/CFS, or does the disease lead to dysbiosis? Does correcting the dysbiosis improve symptoms?
What This Study Does Not Prove
This study shows association, not causation—we cannot conclude that dysbiosis causes ME/CFS or that correcting it will reverse the disease. The cross-sectional design means we don't know if dysbiosis precedes disease onset or develops as a consequence of being ill. Results cannot be generalized beyond the specific patient population studied.